- Investing Ideas
- /
- German Pharmaceuticals & Biotech High Growth Potential Companies
German Pharmaceuticals & Biotech High Growth Potential Companies
Results
6
Companies with a Future performance score of at least 3, ordered by Future performance score.
6 companies
Cantourage Group
Market Cap: €30.8m
Operates as a medical cannabis company in Europe.
HIGH
€2.47
7D
-16.0%
1Y
-46.5%
SynBiotic
Market Cap: €19.9m
Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.
SBX
€2.93
7D
0%
1Y
-47.6%
Formycon
Market Cap: €399.2m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€22.60
7D
-2.8%
1Y
-53.0%
Evotec
Market Cap: €941.3m
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€5.30
7D
1.6%
1Y
-43.2%
Gerresheimer
Market Cap: €838.6m
Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.
GXI
€24.28
7D
-0.2%
1Y
-67.6%
Bayer
Market Cap: €30.1b
Operates as a life science company worldwide.
BAYN
€30.60
7D
9.5%
1Y
53.5%